Effects on agitation with rivastigmine patch monotherapy and combination therapy with memantine in mild to moderate Alzheimer's disease: a multicenter 24-week prospective randomized open-label study (the Korean EXelon Patch and combination with mEmantine

Advancements in the treatment of agitation in Alzheimer’s disease

(2015) Inga M Antonsdottir et al.   EXPERT OPINION ON PHARMACOTHERAPY

Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition

(2014) Jeffrey Cummings et al.   INTERNATIONAL PSYCHOGERIATRICS

Effect of Citalopram on Agitation in Alzheimer Disease

(2014) Anton P. Porsteinsson et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Management of Neuropsychiatric Symptoms of Dementia in Clinical Settings: Recommendations from a Multidisciplinary Expert Panel

(2014) Helen C. Kales et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Safety and Effectiveness of Donepezil on Behavioral Symptoms in Patients With Alzheimer Disease

(2011) Manuel Martin Carrasco et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Lack of Evidence for the Efficacy of Memantine in Mild Alzheimer Disease

(2011) Lon S. Schneider   ARCHIVES OF NEUROLOGY

Tolerability and efficacy of memantine add-on therapy to rivastigmine transdermal patches in mild to moderate Alzheimer's disease: a multicenter, randomized, open-label, parallel-group study

(2011) Seong Hye Choi et al.   CURRENT MEDICAL RESEARCH AND OPINION

Neuropsychiatric Symptoms and the Risk of Institutionalization and Death: The Aging, Demographics, and Memory Study

(2011) Toru Okura et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Caregiver Burden and Neuropsychiatric Symptoms in Older Adults With Cognitive Impairment

(2010) Toru Okura et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Prevalence of Neuropsychiatric Symptoms and Their Association with Functional Limitations in Older Adults in the United States: The Aging, Demographics, and Memory Study

(2010) Toru Okura et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimer’s disease: a post hoc analysis

(2009) Martin R. Farlow et al.   CURRENT MEDICAL RESEARCH AND OPINION

Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine

(2009) Joanne Rodda et al.   INTERNATIONAL PSYCHOGERIATRICS

Memantine Treatment in Patients with Mild to Moderate Alzheimers Disease Already Receiving a Cholinesterase Inhibitor: A Randomized, Double-Blind, Placebo-Controlled Trial

(2008) Anton Porsteinsson et al.   Current Alzheimer Research

An adaptation of the Korean mini-mental state examination (K-MMSE) in elderly Koreans: Demographic influence and population-based norms (the AGE study)

(2007) Changsu Han et al.   ARCHIVES OF GERONTOLOGY AND GERIATRICS

Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis

(2007) S. Gauthier et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Donepezil markedly potentiates memantine neurotoxicity in the adult rat brain

(2006) Catherine E. Creeley et al.   NEUROBIOLOGY OF AGING